MARKET PULSE-Cytori, Endo Health, Leapfrog, AOL, Cognizant
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s)
Nov 5 (Reuters) - U.S. stock index futures retreated on Tuesday. S&P 500 futures fell 0.29 percent, Dow Jones industrial average futures fell 0.34 percent and Nasdaq 100 futures fell 0.34 percent.
** CYTORI THERAPEUTICS INC, Monday close $2.09, up 51 pct premarket
The medical device maker said on Monday it would receive up to $531 million from Chinese company Lorem Vascular as license fee for its stem cell therapy that removes fat cells from a patient's body. These cells, which are then injected into the affected area, increase blood profusion and heal the wound. Lorem will market the therapy in Asia-Pacific.
** ENDO HEALTH SOLUTIONS INC, Monday close $43.64, up 14.5 pct premarket
The specialty pharmaceutical company said it would acquire Canadian peer Paladin Labs Inc for about $1.6 billion to expand its presence in Canada and emerging markets.